Search Within

Viktoriya Paroder

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (4)
  3. Review (3)
Groups
  1. Body Imaging Service (13)
  2. Molecular Imaging and Therapy Service (13)
  3. Radiology, Department of (13)
  4. Department of Medicine (10)
  5. Solid Tumor Oncology Division (10)
  6. Gastrointestinal Oncology Service (9)

More Groups

People
  1. Neeta Pandit-Taskar (7)
  2. Yelena Janjigian (7)
  3. Geoffrey Ku (6)
  4. Jason Lewis (6)
  5. Marinela Capanu (6)
  6. Steven Maron (6)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (1)
  6. 2019 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. American Journal of Roentgenology (2)
  3. Journal of Nuclear Medicine (2)
  4. Abdominal Radiology (1)
  5. Annals of Oncology (1)
  6. Cancers (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (3)
  2. American Roentgen Ray Society (2)
  3. Society of Nuclear Medicine (2)
  4. American Association for Cancer Research (1)
  5. Elsevier Inc. (1)
  6. MDPI (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • (18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer
    Journal Article

    Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: Impact on documentation of disease sites and physician satisfaction
    Journal Article

    Andrieu, P. C.; Nikolovski, I.; Juluru, K.; Sadowski, E.; Gangai, N.; Zheng, J.; Capanu, M.; Praiss, A. M.; Nougaret, S.; Shinagare, A. B.; more...
    American Journal of Roentgenology (2023)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) in esophagogastric cancer using (89)Zr-trastuzumab PET: A pilot study
    Journal Article

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Chou, J. F.; Capanu, M.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Lyashchenko, S. K.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Feasibility, safety, and biodistribution of 18F-BMS-986229 PET in patients with esophagogastric (EG) cancer
    Meeting Abstract

    Cytryn, S.; Lumish, M.; Paroder, V.; Philemond, S.; Lewis, J.; Lyashchenko, S.; Janjigian, Y.; Pandit-Taskar, N.
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Can (18)F-FDG PET/CT radiomics features predict clinical outcomes in patients with locally advanced esophageal squamous cell carcinoma?
    Journal Article

    Jayaprakasam, V. S.; Gibbs, P.; Gangai, N.; Bajwa, R.; Sosa, R. E.; Yeh, R.; Greally, M.; Ku, G. Y.; Gollub, M. J.; Paroder, V.
    Cancers (2022)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Imaging HER2-positive metastatic esophagogastric cancer with (89)Zr-trastuzumab PET and (18)F-FDG PET
    Meeting Abstract

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Janjigian, Y. Y.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Variants and pitfalls in PET/CT imaging of gastrointestinal cancers
    Review

    Jayaprakasam, V. S.; Paroder, V.; Schòˆder, H.
    Seminars in Nuclear Medicine (2021)

    Fulltext@MSK | Save